文献速递焦虑、强迫与应激相关障碍

靶向内源性大麻素系统治疗创伤后应激障碍:临床前与临床转化的 promising 案例?

Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?
PubMed 文献 · Biol Psychiatry · 2021-07-24

本文综述了内源性大麻素系统在创伤后应激障碍治疗中的转化研究。临床前研究表明,杏仁核内CB1受体激活对恐惧记忆消退至关重要,而恐惧消退失败是PTSD核心症状。近期人类数据支持动物研究发现,提示靶向eCB系统可能具有治疗潜力。

要点

  • 临床前证据表明CB1受体激活是恐惧消退的关键机制
  • 直接CB1激活(THC)或间接增强(FAAH抑制)是潜在策略
  • 近期人类数据支持动物发现向临床转化

核心结论

  • 现有临床前和人类数据支持靶向内源性大麻素系统治疗PTSD的转化潜力。

研究设计与样本

  • 综述类文章,检索范围未明确报告。

主要发现

  • 临床前研究显示eCB活动影响前额叶皮层与杏仁核的功能连接,从而影响应对威胁和应激的能力。
  • 动物研究表明杏仁核内CB1受体激活对恐惧记忆消退至关重要。
  • 人类数据一致支持动物恐惧记忆和应激反应性发现的转化。

关键数值与推荐

  • 直接CB1受体激活策略包括使用Δ9-四氢大麻酚或其合成类似物。
  • 间接增强策略包括抑制eCB降解酶:anandamide降解酶FAAH或2-AG降解酶MAGL。

临床怎么用

  • 临床可关注直接CB1激活(如THC)或间接增强(如FAAH抑制)策略的转化应用。

局限性

  • 原文未明确报告综述的检索范围等设计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The endocannabinoid (eCB) system is one the most ubiquitous signaling systems of the brain and offers a rich pharmacology including multiple druggable targets. Preclinical research shows that eCB activity influences functional connectivity between the prefrontal cortex and amygdala and thereby influences an organism's ability to cope with threats and stressful experiences. Animal studies show that CB1 receptor activation within the amygdala is essential for extinction of fear memories. Failure to extinguish traumatic memories is a core symptom of posttraumatic stress disorder, suggesting that potentiating eCB signaling may have a therapeutic potential in this condition. However, it has been unknown whether animal findings in this domain translate to humans. Data to inform this critical question are now emerging and are the focus of this review. We first briefly summarize the biology of the eCB system and the animal studies that support its role in fear extinction and stress responding. We then discuss the pharmacological eCB-targeting strategies that may be exploited for therapeutic purposes: direct CB1 receptor activation, using Δ9-tetrahydrocannabinol or its synthetic analogs; or indirect potentiation, through inhibition of eCB-degrading enzymes, the anandamide-degrading enzyme fatty acid amide hydrolase; or the 2-AG (2-arachidonoyl glycerol)-degrading enzyme monoacylglycerol lipase. We then review recent human data on direct CB1 receptor activation via Δ9-tetrahydrocannabinol and anandamide potentiation through fatty acid amide hydrolase blockade. The available human data consistently support a translation of animal findings on fear memories and stress reactivity and suggest a potential therapeutic utility in humans.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Mayo LM, Rabinak CA, Hill MN, et al. Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation? Biol Psychiatry. 2021. PMID: 34598785. doi:10.1016/j.biopsych.2021.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。